Liver disease patients could one day benefit from a new macrophage cell therapy that has just completed its first clinical trial, published in Nature Medicine (07 October 2019). Professor Stuart Forbes (MRC Centre for Regenerative Medicine) describes the results of this safety clinical trial. http://www.crm.ed.ac.uk/news/macrophage-cell-therapy-safe-trial-suggests
Videography: Jessie Pearson, Robin Morton and Ellie Roger
The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.
Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.